Great leaders don’t chase quick answers. They linger on the question that changes everything—and keeps the conversation ...

Fifteen years into their remarkable run as Golden State Warriors owners, Joe Lacob and Peter Guber reflect on the wild ...

Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...

The Nasdaq 100 enjoyed one of those well-timed Friday afternoon rallies (1.9% off morning trading lows) to somewhat ease ...

The RBI’s 2025 Master Direction expands eligible collateral for repo transactions to include municipal debt securities, enhancing liquidity options for market ...

See how MS Word Agent Mode automates edits, integrates Excel data, and builds tables, while Copilot Chat summarizes and drafts content inside docs ...

For every published book, numerous others die before ink reaches the page, before anyone gets a chance to read what the ...